Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Earth Science Tech ( (ETST) ) has provided an update.
On August 8, 2025, Earth Science Tech, Inc. reported a 61% growth in total assets to $7.69 million and revenue of $8.7 million for the first quarter ending June 30, 2025. This growth follows a foundational quarter of strategic acquisitions, including healthcare and direct-to-consumer brands, and marks a shift from acquisitions to enhancing the value and profitability of existing divisions. The company also reduced its outstanding shares by 4.78% and continued to expand its operational infrastructure, including a new customer service center and real estate development projects.
Spark’s Take on ETST Stock
According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.
The overall stock score of 65.75 reflects strong recent financial performance and positive corporate events, which are the most significant factors. Technical analysis supports a positive outlook with slight momentum. Valuation remains a moderate factor with a fair P/E ratio, while the lack of dividend yield could be a drawback for some investors.
To see Spark’s full report on ETST stock, click here.
More about Earth Science Tech
Earth Science Tech, Inc. is a strategic holding company focused on acquiring and scaling high-potential operating businesses. The company operates in industries including compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries such as RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, and others.
Average Trading Volume: 86,518
Technical Sentiment Signal: Buy
Current Market Cap: $51.5M
See more insights into ETST stock on TipRanks’ Stock Analysis page.